Hong Shen
- Cancer Research top 2%
- MicroRNA in disease regulation 10
- Hepatology top 2%
- Liver physiology and pathology 15
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 13
- Cancer Cells and Metastasis 10
- Colorectal Cancer Treatments and Studies 9
- Molecular Biology top 5%
- TGF-β signaling in diseases 10
-
- Ferroptosis and cancer prognosis 13
-
- Liver Disease Diagnosis and Treatment 10
- Cited by
- Cancer ResearchHepatologyOncology
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (2 papers)ACS Nano (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Hong Shen
164 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 1.0k
- Hepatology 332
- Oncology 1.1k
- Molecular Biology 2.1k
- Pulmonary and Respiratory Medicine 770
Countries citing papers authored by Hong Shen
This map shows the geographic impact of Hong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Shen more than expected).
Fields of papers citing papers by Hong Shen
This network shows the impact of papers produced by Hong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Shen. The network helps show where Hong Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hong Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 5 | |
| 4 | 2025 | 8 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 23 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 1 | |
| 12 | 2021 | 25 | |
| 13 | 2021 | 52 | |
| 14 | 2020 | 30 | |
| 15 | 2020 | 23 | |
| 16 | 2018 | 48 | |
| 17 | 2016 | 0 | |
| 18 | 2016 | 73 | |
| 19 | 2015 | 2 | |
| 20 | 2007 | 5 |
About Hong Shen
Hong Shen is a scholar working on Cancer Research, Hepatology and Oncology, having authored 172 papers that have together received 4.4k indexed citations. Recurring topics across this work include Liver physiology and pathology (15 papers), Cancer Immunotherapy and Biomarkers (13 papers), Ferroptosis and cancer prognosis (13 papers), MicroRNA in disease regulation (10 papers), Cancer Cells and Metastasis (10 papers), Liver Disease Diagnosis and Treatment (10 papers), TGF-β signaling in diseases (10 papers) and Colorectal Cancer Treatments and Studies (9 papers). The work is most often cited by research in Cancer Research (1.0k citations), Hepatology (332 citations) and Oncology (1.1k citations). Hong Shen has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Shan Zeng, Ying Han, Changjing Cai, Junli Ma, Cao Guo, Yihan Liu, Yuewen Gong, Wantao Wu, Ganlu Deng and Yaojie Fu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.